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Abstract
Noroviruses and other viral pathogens are increasingly recognized as frequent causes of
acute gastroenteritis (AGE). However, few laboratory-based data are available on the inci-
dence of AGE caused by viral pathogens in the U.S. This study examined stool specimens
submitted for routine clinical diagnostics from patients enrolled in Kaiser Permanente (KP)
health plans in metro Portland, OR, and the Maryland, District of Columbia, and northern
Virginia geographic areas to estimate the incidence of viral enteropathogens in these popu-
lations. Over a one-year study period, participating laboratories randomly selected stools
submitted for routine clinical diagnostics for inclusion in the study along with accompanying
demographic and clinical data. Selected stools were tested for norovirus, rotavirus, sapo-
virus, and astrovirus using standardized real-time RT-PCR protocols. Each KP site provided
administrative data which were used in conjunction with previously published data on
healthcare utilization to extrapolate pathogen detection rates into population-based inci-
dence rates. A total of 1,099 specimens collected during August 2012 to September 2013
were included. Mean age of patients providing stool specimens was 46 years (range: 0–98
years). Noroviruses were the most common viral pathogen identified among patients with
AGE (n = 63 specimens, 6% of specimens tested). In addition, 22 (2%) of specimens were
positive for rotavirus; 19 (2%) were positive for sapovirus; and 7 (1%) were positive for
astrovirus. Incidence of norovirus-associated outpatient visits was 5.6 per 1,000 person-
years; incidence of norovirus disease in the community was estimated to be 69.5 per 1,000
person-years. Norovirus incidence was highest among children <5 years of age (outpatient
incidence = 25.6 per 1,000 person-years; community incidence = 152.2 per 1,000 person-
years), followed by older adults aged >65 years (outpatient incidence = 7.8 per 1,000
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person-years; community incidence = 75.8 per 1,000 person-years). Outpatient incidence
rates of rotavirus, sapovirus, and astrovirus were 2.0, 1.6, 0.6 per 1,000 person-years,
respectively; community incidence rates for these viruses were 23.4, 22.5, and 8.5 per
1,000 person-years, respectively. This study provides the first age-group specific labora-
tory-based community and outpatient incidence rates for norovirus AGE in the U.S. Norovi-
rus was the most frequently detected viral enteropathogen across the age spectrum with
the highest rates of norovirus disease observed among young children and, to a lesser
extent, the elderly. These data provide a better understanding of the norovirus disease bur-
den in the United States, including variations within different age groups, which can help
inform the development, targeting, and future impacts of interventions, including vaccines.
Background
Acute gastroenteritis (AGE), characterized by sudden onset of symptoms including diarrhea,
vomiting, nausea, and abdominal pain, is a major cause of morbidity in the United States.
Approximately 179 million cases of AGE are estimated to occur annually in the United States,
resulting in 600,000 hospitalizations and an estimated 5,000 deaths [1, 2]. Viruses have been
found to be the most common known agents of AGE. Noroviruses specifically are estimated to
cause approximately 19–21 million cases of AGE annually, including 56,000–71,000 hospitali-
zations and 570–800 deaths [3]. With wide diversity of noroviruses in circulation and lack of
persistent cross-protective immunity, on average, a U.S. resident experiences five norovirus
episodes in his or her lifetime [3]. Other viruses such as rotavirus, astrovirus, and sapovirus are
also important agents of AGE, especially among children. Diarrhea healthcare utilization has
been dramatically reduced among children under 5 years due to rotavirus vaccination in the
United States [4, 5]. The burden of AGE disease in the United States attributable to sapoviruses
and astroviruses is less clear and studies have been limited to children less than 5 years of age
[6] and to members of a health maintenance organization in one state [7].
Early estimates of the burden and incidence of norovirus AGE in the United States were
based on extrapolations of etiologic fractions from studies in other industrialized countries [2,
8], but more recent estimates have included direct testing for viral pathogens in fecal specimens
[7, 9]. Laboratory-confirmed population-based estimates of norovirus AGE in the U.S. remain
limited to pediatric populations and all-ages estimates, which were not adequately powered to
provide age-specific rates [7, 9, 10]. Age-stratified rates of norovirus AGE covering the full age
spectrum in other industrialized countries are even rarer and have only been estimated for the
United Kingdom. [11].
Direct assessments of laboratory-confirmed, age-specific incidence of norovirus AGE are
needed to assess the need and potential impacts of targeted interventions. Continued develop-
ment and subsequent implementation of candidate norovirus vaccines must be built upon reli-
able age-specific incidence estimates for the U.S. [12]. To address this need, our primary
objective was to estimate age-specific incidence rates of norovirus AGE among members of
Kaiser Permanente (KP) health plans in metro Portland, OR, and the Maryland, District of
Columbia, and northern Virginia geographic areas from 2012–2013. Our secondary objective
was to generate all-ages estimates of the incidence of other viral pathogens associated with
AGE, specifically rotavirus, sapovirus, and astrovirus.
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Methods
Study Sites and Data Collection
This study was conducted in conjunction with the Mid-Atlantic and Northwest regions within
the KP health maintenance organization. The Kaiser Mid-Atlantic region consists of approxi-
mately 488,000 members and encompasses the Washington, D.C. metropolitan area, including
portions of Maryland and Virginia. The Kaiser Northwest region consists of approximately
480,000 members within the metropolitan area of Portland, Oregon, including areas of north-
west Oregon and southwestern Washington. Members of KP almost exclusively seek care
within the organization.
Diagnostic stool specimens submitted for routine clinical testing (i.e., bacterial culture)
from all outpatients who sought medical care at each KP site were randomly selected for inclu-
sion in this study. A target minimum sample size of 511 specimens from each site was deter-
mined based on power calculations using expected values from previous studies (i.e., 5%
expected norovirus prevalence, assuming that stool specimens from cases of non-bloody diar-
rhea of3 days duration are 7 times less likely to be collected than from all cases of diarrhea)
[7]. The precision of overall norovirus incidence increases when the number of specimens
exceeds the targeted sample size. Only patients for whom a specimen was submitted after a cli-
nician order for routine bacterial culture, ova and parasite test, or for the presence of Clostrid-
ium difficile were eligible for inclusion, although more than one diagnostic test may have been
ordered for the same patient.
Demographic and clinical data collected for each specimen included age of patient (in
years), gender, dates of illness onset and specimen collection, chief complaint (International
Classification of Diseases, Clinical Modification [ICD-9 CM] code), and diagnostic tests that
were performed and their results. De-identified demographic and clinical data and results of
laboratory testing were sent to the Centers for Disease Control and Prevention (CDC), Atlanta,
GA, USA for analysis. Data and specimens were anonymized and contained no identifying
information that could be linked to the patient. This study was determined by CDC human
subjects review to be non-research public health practice and thus did not require institutional
review board review.
Laboratory Testing
Routine diagnostics on specimens collected among KP Northwest members were performed at
the KP Northwest microbiology laboratory for Campylobacter, Shigella, Salmonella, and E. coli
O157:H7 and for the presence of Shiga toxins 1 and 2. In addition, this laboratory tested some
specimens for ova and parasites and for the presence of C. difficile toxin and glutamate dehy-
drogenase (GDH). Tests with mixed results were reflex-tested for toxin genes using PCR. Spec-
imens collected among KP Mid-Atlantic members were tested at the KP Mid-Atlantic
microbiology laboratory for Campylobacter, Shigella, Salmonella, and Yersinia enterocolitica, as
well as ova and parasites, and C. difficile toxin A and B by EIA in some specimens.
Specimens were tested for viral AGE pathogens at the Oregon State Public Health and
Maryland Department of Health and Mental Hygiene laboratories. Viral nucleic acid was
extracted using the KingFisher MagMax 96 viral RNA extraction kit (Life Technologies, Carls-
bad, CA, USA). All specimens were tested for the presence of norovirus, sapovirus, astrovirus,
and rotavirus RNA by using the AgPath-ID One-Step RT-PCR Kit (Applied Biosystems, Foster
City, CA, USA) on the 7500 Realtime PCR platform (Applied Biosystems) [13–16].
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Disease Incidence Calculations
Each KP site provided the total population catchment (e.g., membership) to be used as the
denominator for incidence calculations. Additionally, each KP site identified the total number
of stool specimens that were submitted for diagnostic testing and the total number of patients
with AGE presenting for care during the study period. AGE diagnoses for patients presenting
to care were extracted and defined using a previously described set of ICD9-CM codes [17].
Pooled data on self-reported healthcare utilization practices of persons with AGE that were
obtained from the Foodborne Diseases Active Surveillance Network (FoodNet) population sur-
veys in 2000–2001, 2002–2003, and 2006–2007 [7]. These population-based telephone surveys
were conducted in selected sites located throughout the United States, including Oregon,
Washington, and Maryland by using a probability sample design. Data from these surveys
were used to estimate healthcare-seeking rates among KP members with AGE in order to
derive incidence estimates at the community level, including those that do not seek outpatient
care.
Community and outpatient incidence of each viral pathogen was calculated on the basis of
the prevalence of that pathogen in sampled stool specimens (Pi), age-weighted stool specimen
submission rates among all respondents with AGE (ComSSi) and that among those seeking
medical care (OutSSi), the total number of specimens submitted to the KP laboratories during
the study period (S), and the total Kaiser membership at each site (N) (Fig 1). Thus, commu-
nity incidence estimates were adjusted for both stool specimen submission and medical care-
seeking rates, while outpatient incidence estimates were adjusted using only stool specimen
submission rates. Age-specific estimates of norovirus incidence were calculated using the fol-
lowing age groups:<5, 5–15, 16–25, 26–45, 46–65, and>65 years. These age groups were
broadly selected for clinical relevance and consistency in health care utilization rates. Incidence
estimates were adjusted for age-specific variations in the proportion of stool specimens that
were collected due to AGE being a chief complaint of the patient. A simulation approach was
used to generate 95% credible intervals (CIs). For each pathogen or group of pathogens, Pi,
ComSSi, and OutSSi were randomly drawn assuming a normal distribution for each, and the 2
incidence equations were recalculated. We report 2.5th and 97.5th centiles of 100,000 simula-
tions. Analyses were performed by using SAS version 9.3 (SAS Institute, Cary, NC, USA).
Results
A total of 1,099 specimens were randomly selected for inclusion in this study and tested for
viral pathogens (Table 1). Fifty-five percent (n = 600) were collected among KP Northwest
members, and 45% (n = 499) were collected among KP Mid-Atlantic members. Tested speci-
mens were collected an average of 3 days after date of illness onset; 90% of specimens were col-
lected within 7 days of illness onset. Fifty-seven percent (n = 630) of patients had an AGE chief
complaint code when presenting for care. Routine bacterial culture was performed for 93%
(n = 1018) of specimens; 51% (n = 558) were tested for C. difficile and 30% (n = 326) were
tested for ova and parasites. Adult patients 46–65 years of age provided 33% (n = 360) of the
specimens tested. One or more non-viral pathogens that cause AGE were found in 117 (11%)
specimens, of which 68 (58%) were obtained from KP Northwest patients and 49 (42%) were
obtained from KP Mid-Atlantic patients. Of these non-viral pathogens, patients were most
commonly infected with C. difficile (n = 49, 9% of specimens tested). In addition, 32 (3%) of
tested patients had a positive bacterial culture and 26 (8%) had evidence of ova or parasites.
Noroviruses were the most common viral pathogen identified among patients with AGE; 63
specimens (6%) were positive for norovirus (Table 1). Additionally, 22 (2%) of specimens were
positive for rotavirus; 19 (2%) were positive for sapovirus; and 7 (1%) were positive for
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astrovirus. Three percent of children under 5 years of age with AGE were rotavirus-positive, as
were 3% of adults over 65 years of age. Patients aged 5–15 years and 16–25 years of age were
most commonly infected with sapoviruses (3% among each age category). Three (43%) of the
seven patients who were positive for astrovirus infection were aged 46–65 years. Eighty-six per-
cent (n = 55) of norovirus-positive specimens were classified as genogroup (G) II. The preva-
lence of norovirus-positive stool specimens was highest between November and March (Fig 2).
The prevalence of sapovirus-, astrovirus-, and rotavirus-positive specimens were highest dur-
ing March and April.
Fig 1. Equations used for calculation of community and outpatient incidence of viral pathogen in
patients with acute gastroenteritis (AGE).
doi:10.1371/journal.pone.0148395.g001
Table 1. Characteristics of randomly selected stool specimens submitted by outpatients, by age group, to Kaiser Permanente Northwest and Mid-
Atlantic Health Plans, 2012–2013.
Stool Specimen
Characteristic














Tested by bacterial culture 65 (96) 70 (97) 85 (87) 228 (91) 333 (93) 237 (94) 1018 (93)
Tested for C. difficile 17 (25) 13 (18) 45 (46) 111 (44) 211 (59) 155 (62) 552 (50)
Tested for ova and
parasites
18 (26) 27 (38) 33 (34) 82 (33) 109 (30) 57 (23) 326 (30)
Total norovirus-positive 8 (12) 4 (6) 4 (6) 13 (5) 22 (6) 12 (5) 63 (6)
Norovirus GI 1 (13) 1 (25) 0 3 (23) 0 3 (25) 8 (13)
Norovirus GII 7 (87) 3 (75) 4 (100) 10 (77) 22 (100) 9 (75) 55 (87)
Sapovirus-positive 1 (1) 2 (3) 3 (3) 5 (2) 7 (2) 1 (0.4) 19 (2)
Astrovirus-positive 1 (1) 0 1 (1) 2 (1) 3 (1) 0 7 (1)
Rotavirus-positive 2 (3) 1 (1) 1 (1) 4 (2) 7 (2) 7 (3) 22 (2)
doi:10.1371/journal.pone.0148395.t001
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A total of 53,521 unique patient encounters with ICD-9CM codes consistent with AGE
were identified during the study period (September 2012–September 2013 for KP Northwest,
and August 2012–July 2013 for KP Mid-Atlantic), during which 6,038 stool specimens were
submitted for routine clinical diagnostics (see S1 Table). Using these site-specific data along
with FoodNet population survey healthcare seeking rates, the overall community incidence of
norovirus-associated AGE was 68.9 per 1,000 person-years (95% credible interval: 57.7, 77.1
per 1,000) (Fig 3), while the overall incidence of norovirus-associated AGE among outpatients
was 5.6 per 1,000 person-years (95% credible interval: 5.3, 5.9 per 1,000) (Fig 4). Norovirus-
associated AGE incidence among KP Northwest members (community incidence: 76.9 per
1,000 person-years; outpatient incidence: 6.5 per 1,000 person-years (95% credible interval: 6.0,
7.0 per 1,000)) was similar to that among KP Mid-Atlantic members (community incidence:
61.8 per 1,000 person-years; outpatient incidence: 4.7 per 1,000 person-years). Norovirus-asso-
ciated AGE incidence in the community was highest among children less than five years of age
(152.1 per 1,000 person-years), followed by persons 46–65 years of age (101.2 per 1,000 per-
son-years). Incidence of outpatient norovirus-associated AGE was also highest among children
less than five years of age (25.6 per 1,000 person-years) followed by persons over 65 years of
age (7.9 per 1,000 person-years).
Sapovirus-associated AGE incidence in the community was estimated at 22.7 per 1,000 per-
son-years (95% credible interval: 17.4, 23.2 per 1,000), while incidence of sapovirus-associated
outpatient visits was estimated at 1.6 per 1,000 person-years (95% credible interval: 1.6, 1.8 per
1,000) (Table 2). Sapovirus incidence was higher among KP Mid-Atlantic members when com-
pared to KP Northwest members (community incidence: 28.6 vs. 17.8 per 1,000 person-years,
respectively; outpatient incidence: 2.0 vs. 1.3 per 1,000 person-years, respectively). Rotavirus-
associated AGE community incidence was estimated at 23.7 per 1,000 person-years (95% credi-
ble interval: 20.2, 26.9 per 1,000), while outpatient incidence was estimated at 1.9 per 1,000 per-
son-years (95% credible interval: 1.9, 2.1 per 1,000). Site-specific rotavirus AGE incidence
estimates were similar. Astrovirus-associated AGE community incidence was estimated at 8.5
Fig 2. Viral pathogen prevalence in acute gastroenteritis outpatients by season, Kaiser Permanente Northwest and Mid-Atlantic Health Plans,
September 2012–August 2013.
doi:10.1371/journal.pone.0148395.g002
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per 1,000 person-years (95% credible interval: 6.4, 8.6 per 1,000), while outpatient incidence
was estimated at 0.6 per 1,000 person-years (95% credible interval: 0.6, 0.7 per 1,000). Astro-
virus incidence was roughly three times higher among KP Mid-Atlantic members (Table 2).
Age-specific incidence estimates for sapovirus, rotavirus, and astrovirus AGE were not
Fig 3. Estimated community incidence of norovirus AGE among outpatients in Kaiser Permanente Northwest and Mid-Atlantic Health Plans, by
age group, 2012–2013.
doi:10.1371/journal.pone.0148395.g003
Fig 4. Estimated incidence of norovirus AGE among outpatients in Kaiser Permanente Northwest and Mid-Atlantic Health Plans, by age group,
2012–2013.
doi:10.1371/journal.pone.0148395.g004
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calculated due to the relatively low prevalence of each virus among submitted specimens in
some age strata.
Discussion
This study represents an important advancement in norovirus epidemiology by providing the
first U.S. laboratory-based age-specific norovirus AGE incidence rates in both community and
outpatient settings. This study is also one of few to report the incidence of AGE associated with
rotavirus, astrovirus, and sapovirus across the full age spectrum at the community and outpa-
tient levels. Approximately 6% of specimens submitted for routine bacterial culture at the two
KP study sites were positive for norovirus, and the highest norovirus prevalence was identified
among specimens collected from children less than 5 years of age, consistent with previous
findings from a similar study [7]. Furthermore, the prevalence of viral pathogens that cause
AGE were highest in the winter and early spring months, consistent with previous descriptions
of norovirus and rotavirus seasonality in temperate climates [18, 19]. A very high proportion
of norovirus-positive specimens were genogroup GII, as expected from earlier reports [10, 20,
21].
Our all-ages norovirus incidence estimates for outpatient (5.6 per 1,000 person-years) and
community (68.9 per 1,000 person-years) settings are consistent with earlier studies in the U.S.
and other developed countries. Our results are very similar to the outpatient and community
norovirus incidence of 6.4 cases and 65 cases per 1,000 person-years, respectively as reported
by Hall et al for a KP population in Georgia [7]. Gastanaduy et al. [22] reported a similar U.S.
outpatient incidence rate of norovirus AGE at 5.7 per 1,000 and Scallan et al. [23] reported a
similar U.S. community norovirus incidence of 70 per 1,000. Our estimated outpatient inci-
dence estimates are similar to those reported in Germany (6.3 per 1,000 person-years) [24] and
England (5.4 per 1,000 person-years) [11]. In contrast, our outpatient incidence estimate was
much lower than one estimate reported from The Netherlands (9.2 per 1,000) [25], but also
much higher than a similar study conducted in the United Kingdom (2.1 per 1,000) [26]. Our
community incidence estimate is somewhat similar to estimates reported by two studies in the
UK (45–47 per 1,000) [11, 26], while community incidence reported by a Dutch study was
lower (38 per 1,000) [25] and a Canadian community incidence estimate was much higher
(104 per 1,000) [27]. Differences in healthcare systems and healthcare utilization practices
likely account for at least some of the observed differences in norovirus incidence among these
countries.
Some of our age-specific norovirus incidence estimates are consistent with age-specific esti-
mates reported from one study in the United Kingdom [11]. Our age-specific outpatient inci-
dence estimates among children under 5 years (25.6 per 1,000) and children aged 5–15 years
(3.7 per 1,000) are similar to the United Kingdom incidence estimates for children under 5
Table 2. Outpatient and community incidence of viral pathogens that cause AGE, by site.
Virus Outpatient incidence per 1,000 person-years (95%
credible interval)
Community incidence per 1,000 person-years (95% credible
interval)
Northwest Mid-Atlantic Both Sites Northwest Mid-Atlantic Both Sites
Norovirus 6.5 (6.0, 7.0) 4.7 (4.4, 5.2) 5.6 (5.3, 5.9) 76.9 (66.3, 90.1) 61.8 (48.1, 65.8) 68.9 (57.7, 77.1)
Sapovirus 1.3 (1.2, 1.4) 2.0 (1.9, 2.3) 1.6 (1.6, 1.8) 17.8 (12.9, 17.5) 28.6 (21.4, 29.2) 22.7 (17.4, 23.2)
Astrovirus 0.4 (0.3, 0.4) 0.8 (0.8, 1.0) 0.6 (0.6, 0.7) 3.8 (3.7, 5.0) 12.8 (8.9, 12.2) 8.5 (6.4, 8.6)
Rotavirus 2.1 (1.8, 2.1) 1.9 (1.8, 2.1) 1.9 (1.9, 2.1) 21.1 (20.3, 27.5) 26.5 (19.6, 26.8) 23.7 (20.2, 26.9)
doi:10.1371/journal.pone.0148395.t002
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years of age (32 per 1,000) and 5–14 years of age (4.4 per 1,000). Conversely, our outpatient
incidence rates for older adults (aged 46–65 years: 5.5 per 1,000; over age 65 years: 7.9 per
1,000) were at least twice the outpatient incidence rates reported among these similar age
groups (45–64 years: 2.6 per 1,000; 65 years of age and older: 3.7 per 1,000). Differences in age
categories used between these studies limit our ability to compare community incidence rates
across the two studies; however, our age-specific incidence community incidence rates are
markedly lower among children (less than 5 years of age: 152.1 per 1,000; aged 5–15 years: 22.2
per 1,000) than among children participating in the UK study (less than 5 years of age: 214 per
1,000; 5–14 years of age: 65 per 1,000).
As expected, the prevalence and estimated incidence of norovirus were highest among chil-
dren less than 5 years of age in our study. Our estimated outpatient incidence of norovirus
among children less than 5 years of age is similar to that developed through indirect regression
of all-cause AGE from a U.S. insurance claim database [22] as well as that from direct active
surveillance in pediatric clinics [9]. Interestingly, the outpatient and community incidence of
norovirus among Kaiser Permanente Northwest members less than 5 years of age participating
in were approximately twice as high as those among Kaiser Permanente Mid-Atlantic members
in this age group. This is despite the fact that the proportion of persons less than 5 years of age
who submitted a stool specimen of those with AGE who sought medical care was higher
among Kaiser Permanente Mid-Atlantic members (5.3%) than among KP Northwest members
of the same age group (3.8%).
Our estimates of sapovirus incidence (community: 22.7 per 1,000 person-years; outpatient:
1.6 per 1,000 person-years) are somewhat higher than those reported in the previous Georgia
Kaiser Permanente study (community: 9.0 per 1,000 person-years; outpatient: 1.1 per 1,000
person-years) [7], though the credible intervals of the respective estimates were still overlap-
ping. In contrast, our estimated astrovirus incidence rates (community: 8.5 per 1,000 person-
years; outpatient: 0.6 per 1,000 person-years) are substantially lower than those from the Geor-
gia study (community: 18 per 1,000 person-years; outpatient: 2.7 per 1,000 person-years) [7].
Our estimated community rotavirus incidence rate (23.7 per 1,000 person-years) is also higher
than that reported among specimens taken from Georgia KP members in 2004–2005 (8.8 per
1,000 person-years), although our estimated outpatient rotavirus incidence rate (1.9 per 1,000
person-years) is similar to the earlier report (1.5 per 1,000 person-years). These observed dif-
ferences in incidence between the two studies may be due in part to regional or year-to-year
variations.
The principal limitation of this study results from using routinely collected fecal specimens
for bacterial diagnostics to assess the incidence of viral pathogens that cause AGE. Active sys-
tematic collection of specimens from all patients presenting with AGE would likely provide
more accurate incidence estimates. In addition to potentially biasing towards bacterial etiolo-
gies (and thus away from viruses), this sampling approach may have also included some
patients with noninfectious or chronic causes of AGE; this has been attributed as a possible rea-
son for the low detection of norovirus in specimens from similar studies [7, 10]. Indeed, many
specimens were included in our study from patients without an AGE-specific ICD-9CM code,
although ICD coding accuracy has been shown to be suspect [28]. Additionally, given the
potential for viral pathogens to cause asymptomatic infections among healthy individuals,
detection of these viruses among patients with AGE may not always indicate etiology; however
a multi-center case control study of pediatric AGE in the U.S. found these viruses in<5% of
healthy controls [6, 9]. A limitation of our community incidence estimates is the use of some-
what dated national healthcare seeking rates that are based on diarrheal disease. The healthcare
seeking rates from the FoodNet population surveys did include respondents from geographic
areas in our study, but no site-specific healthcare seeking rates were available. In addition, the
AGE Viral Pathogen Incidence among Kaiser Permanente Members
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use of healthcare utilization information based on diarrheal disease may lead to an underesti-
mate of viral pathogens such as norovirus that can cause other signs of AGE (e.g., vomiting) in
the absence of diarrhea. Furthermore, more severe cases of AGE are presumably more likely to
seek care and could bias our results toward increased prevalence of pathogens that cause more
severe symptoms. Finally, our incidence estimates are limited to two metropolitan populations.
While these two populations are on opposite sides of the United States, the incidence estimates
that we have generated cannot be generalized to the United States population.
Population-based surveillance for laboratory-confirmed AGE due to viral pathogens pro-
vides the most direct assessment of disease incidence, despite limitations in generalizability.
The age-specific incidence rates that we have reported serves to identify groups most often
infected and assists in focusing future prevention efforts such as administration of possible
future vaccines. Surveillance platforms that encompass larger populations over longer periods
of time are needed to provide trends in the incidence of AGE due to viral pathogens that are
generalizable to the entire population. Our demonstrated burden of norovirus AGE in the
community and in outpatient settings justifies the effort to develop possible norovirus
vaccines.
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